The question I ask is why should this fall after the offer. Those who want out at 5.5 have accepted those remaining will want more simple as that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025